SELLAS Life Sciences Group, Inc. (SLS)
7.56
-1.41
(-15.72%)
USD |
NASDAQ |
May 21, 16:00
7.74
+0.18
(+2.38%)
After-Hours: 04:29
SELLAS Life Sciences Group Research and Development Expense (TTM) : 17.95M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Rezolute, Inc. | 59.77M |
| Krystal Biotech, Inc. | 54.64M |
| Spero Therapeutics, Inc. | 27.77M |
| Recursion Pharmaceuticals, Inc. | 382.53M |
| Whitehawk Therapeutics, Inc. | 99.41M |